Project BioShield: Consistent financing, markets, indemnity for biodefense vaccine developers needed
WASHINGTON, DC (April 4, 2003): Biotechnology companies are well suited to address the modest commercial opportunities offered by creating safer, more effective and less costly vaccines for biodefense ...
Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats Program Includes Establishing Pharmaceutical ...
MALVERN, Pa.--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, late-stage clinical pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial ...
SAN DIEGO - When President Bush signed Project BioShield into law in July, he said he was immediately making $5.6 billion available to counter such anticipated threats as smallpox genetically ...
Lawmakers who experienced the dangers of anthrax firsthand sent President Bush legislation Wednesday to give private companies $5.6 billion in incentives to develop antidotes to biological and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results